Maj‐Britt Jensen
- Cancer Research top 0.05%
- Oncology top 0.2%
- Surgery top 1%
- Pathology and Forensic Medicine top 0.2%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Marianne EwertzHenning T. MouridsenNiels KromanMarie OvergaardCarsten RoseJens OvergaardMichael KjærPer Syrak Hansen
- Topics
- Breast Cancer Treatment Studies (110 papers)Breast Lesions and Carcinomas (41 papers)HER2/EGFR in Cancer Research (39 papers)
- Cited by
- Cancer ResearchRadiationOncology
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Maj‐Britt Jensen
167 papers receiving 12.2k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 6.5k
- Oncology 4.9k
- Surgery 2.7k
- Pathology and Forensic Medicine 2.5k
- Pulmonary and Respiratory Medicine 2.2k
Countries citing papers authored by Maj‐Britt Jensen
This map shows the geographic impact of Maj‐Britt Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maj‐Britt Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maj‐Britt Jensen more than expected).
Fields of papers citing papers by Maj‐Britt Jensen
This network shows the impact of papers produced by Maj‐Britt Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maj‐Britt Jensen. The network helps show where Maj‐Britt Jensen may publish in the future.
Co-authorship network of co-authors of Maj‐Britt Jensen
This figure shows the co-authorship network connecting the top 25 collaborators of Maj‐Britt Jensen. A scholar is included among the top collaborators of Maj‐Britt Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maj‐Britt Jensen. Maj‐Britt Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | Atezolizumab and nab-paclitaxel for advanced breast cancer in Danish real-world patients. | 0 |
| 9 | 4 | |
| 10 | 57 | |
| 11 | 44 | |
| 12 | 2 | |
| 13 | 11 | |
| 14 | 33 | |
| 15 | 5 | |
| 16 | 27 | |
| 17 | 13 | |
| 18 | RNA Polymerase IV Directs Silencing of Endogenous DNAbreakdown → | 535 |
| 19 | [Mammography screening in the county of Copenhagen. Results of the first three screening rounds]. | 6 |
| 20 | [Mammographic screening in the county of Copenhagen. Clinical consequences of the first three screening rounds]. | 1 |
About Maj‐Britt Jensen
Maj‐Britt Jensen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 184 papers that have together received 12.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (110 papers), Breast Lesions and Carcinomas (41 papers) and HER2/EGFR in Cancer Research (39 papers). The work is most often cited by research in Cancer Research (6.5k citations), Radiation (1.8k citations) and Oncology (4.9k citations). Maj‐Britt Jensen has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Marianne Ewertz, Henning T. Mouridsen, Niels Kroman, Marie Overgaard, Carsten Rose, Jens Overgaard, Michael Kjær, Per Syrak Hansen, C. Gadeberg and Bent Ejlertsen. Their work appears in journals such as Science, New England Journal of Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.